Autopsy Validation Study of the Academic Research Consortium Stent Thrombosis Definition

被引:38
作者
Cutlip, Donald E. [1 ,2 ]
Nakazawa, Gaku [4 ]
Krucoff, Mitchell W. [5 ]
Vorpahl, Marc [3 ]
Mehran, Roxana [6 ]
Finn, Aloke V. [4 ]
Vranckx, Pascal [7 ]
Kimmelstiel, Carey [2 ,3 ]
Berger, Clifford [2 ]
Petersen, John L. [8 ]
Palabrica, Theresa [2 ]
Virmani, Renu [4 ,9 ]
机构
[1] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Harvard Clin Res Inst, Boston, MA USA
[3] Tufts Med Ctr, Dept Cardiol, Boston, MA USA
[4] CVPath Inst Inc, Gaithersburg, MD USA
[5] Duke Univ, Duke Clin Res Inst, Durham, NC USA
[6] Columbia Univ, Cardiovasc Res Fdn, New York, NY USA
[7] Cardialysis, Rotterdam, Netherlands
[8] Swedish Med Ctr, Swedish Heart & Vasc Inst, Seattle, WA USA
[9] Emory Univ, Sch Med, Atlanta, GA USA
关键词
myocardial infarction; stent; thrombosis; DRUG-ELUTING STENTS; CLINICAL-TRIALS; IMPLANTATION;
D O I
10.1016/j.jcin.2011.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study sought to validate the sensitivity and specificity of the Academic Research Consortium's (ARC) classification of stent thrombosis. Background Classification of stent thrombosis according to ARC criteria has become widely accepted. The criteria have not been validated against an autopsy standard. Methods An autopsy registry of 139 subjects with prior coronary stenting underwent detailed histopathological analysis to assess for stent thrombosis. Based on clinical data only, cases were adjudicated according to ARC stent thrombosis criteria, including a proposed modification of the possible classification to include death beyond 30 days due only to sudden death or acute ischemia. Results Autopsy results confirmed 51 cases as positive and 88 as negative for stent thrombosis. Clinical adjudication classified 105 cases as definite (10), probable (31), or possible (64) ARC stent thrombosis. Specificity was high for definite (99%) and definite plus probable (83%) criteria, but sensitivity was poor at 18% and 51%, respectively. Including the possible cases improved sensitivity to 92% but reduced specificity to 34% (58 false positives). The modified possible criteria eliminated 13 false positive cases (specificity = 49%) and was the best approximation of a hypothetical gold standard in a sensitivity analysis if late death represented at least 20% of all stent thrombosis cases. Conclusions In a selected autopsy sample, restricting ARC stent thrombosis to definite or definite plus probable criteria results in substantial under-reporting of confirmed cases. Inclusion of a modified possible classification may provide the best estimate of late and very late stent thrombosis rates. (J Am Coll Cardiol Intv 2011;4:554-9) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:554 / 559
页数:6
相关论文
共 9 条
  • [1] Stent thrombosis late after implantation of first-generation drug-eluting stents - A cause for concern
    Camenzind, Edoardo
    Steg, P. Gabriel
    Wijns, William
    [J]. CIRCULATION, 2007, 115 (11) : 1440 - 1455
  • [2] Cutlip DE, 2001, CIRCULATION, V103, P1967
  • [3] Clinical end points in coronary stent trials - A case for standardized definitions
    Cutlip, Donald E.
    Windecker, Stephan
    Mehran, Roxana
    Boam, Ashley
    Cohen, David J.
    van Es, Gerrit-Anne
    Steg, P. Gabriel
    Morel, Marie-angele
    Mauri, Laura
    Vranckx, Pascal
    McFadden, Eugene
    Lansky, Alexandra
    Hamon, Martial
    Krucoff, Mitchell W.
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 115 (17) : 2344 - 2351
  • [4] Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents 5-Year Final Results of the TAXUS IV Clinical Trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)
    Ellis, Stephen G.
    Stone, Gregg W.
    Cox, David A.
    Hermiller, James
    O'Shaughnessy, Charles
    Mann, Tift
    Turco, Mark
    Caputo, Ronald
    Bergin, Patrick J.
    Bowman, Thomas S.
    Baim, Donald S.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1248 - 1259
  • [5] Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    Iakovou, I
    Schmidt, T
    Bonizzoni, E
    Ge, L
    Sangiorgi, GM
    Stankovic, G
    Airoldi, F
    Chieffo, A
    Montorfano, M
    Carlino, M
    Michev, I
    Corvaja, N
    Briguori, C
    Gerckens, U
    Grube, E
    Colombo, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17): : 2126 - 2130
  • [6] Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
    Joner, Michael
    Finn, Aloke V.
    Farb, Andrew
    Mont, Erik K.
    Kolodgie, Frank D.
    Ladich, Elena
    Kutys, Robert
    Skorija, Kristi
    Gold, Herman K.
    Virmani, Renu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) : 193 - 202
  • [7] Stent thrombosis in randomized clinical trials of drug-eluting stents
    Mauri, Laura
    Hsieh, Wen-hua
    Massaro, Joseph M.
    Ho, Kalon K. L.
    D'Agostino, Ralph
    Cutlip, Donald E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) : 1020 - 1029
  • [8] Vranckx Pascal, 2008, EuroIntervention, V4 Suppl C, pC39
  • [9] Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial
    Weisz, Giora
    Leon, Martin B.
    Holmes, David R., Jr.
    Kereiakes, Dean J.
    Popma, Jeffrey J.
    Teirstein, Paul S.
    Cohen, Sidney A.
    Wang, Hong
    Cutlip, Donald E.
    Moses, Jeffrey W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (17) : 2009 - 1497